Pediatrix Medical Group, Inc. (NYSE:MD) Short Interest Update

Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) saw a significant increase in short interest in the month of May. As of May 31st, there was short interest totalling 1,740,000 shares, an increase of 25.2% from the May 15th total of 1,390,000 shares. Approximately 2.1% of the company's shares are sold short. Based on an average daily volume of 873,400 shares, the short-interest ratio is currently 2.0 days.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on MD. Truist Financial cut their target price on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a research note on Friday, April 11th. UBS Group dropped their price target on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating on the stock in a research report on Monday, May 12th. Finally, Macquarie boosted their price target on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a research report on Thursday, May 8th. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $16.67.

Pediatrix Medical Group Stock Down 1.0%

MD traded down $0.14 on Friday, reaching $13.22. 1,014,841 shares of the company traded hands, compared to its average volume of 798,939. The stock's 50 day moving average price is $13.66 and its 200-day moving average price is $13.94. Pediatrix Medical Group has a 52-week low of $6.62 and a 52-week high of $17.67. The company has a market cap of $1.14 billion, a price-to-earnings ratio of -13.08, a PEG ratio of 0.93 and a beta of 1.27. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.81 and a quick ratio of 1.81.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported $0.33 EPS for the quarter, topping the consensus estimate of $0.25 by $0.08. The company had revenue of $458.36 million during the quarter, compared to the consensus estimate of $451.44 million. Pediatrix Medical Group had a negative net margin of 4.17% and a positive return on equity of 17.43%. The company's revenue for the quarter was down 7.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.20 earnings per share. On average, sell-side analysts expect that Pediatrix Medical Group will post 1.38 EPS for the current fiscal year.

Institutional Trading of Pediatrix Medical Group

Several large investors have recently added to or reduced their stakes in MD. Nomura Asset Management Co. Ltd. lifted its stake in shares of Pediatrix Medical Group by 95.3% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock worth $33,000 after buying an additional 1,220 shares during the last quarter. GAMMA Investing LLC grew its holdings in shares of Pediatrix Medical Group by 219.5% in the 1st quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock worth $37,000 after purchasing an additional 1,765 shares during the last quarter. Parkside Financial Bank & Trust grew its holdings in shares of Pediatrix Medical Group by 36.1% in the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock worth $51,000 after purchasing an additional 1,040 shares during the last quarter. AlphaQuest LLC grew its holdings in Pediatrix Medical Group by 65.9% during the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock worth $66,000 after acquiring an additional 2,012 shares during the last quarter. Finally, Smartleaf Asset Management LLC grew its holdings in Pediatrix Medical Group by 750.9% during the 4th quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock worth $91,000 after acquiring an additional 6,090 shares during the last quarter. 97.71% of the stock is owned by institutional investors.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.